A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4025 (2006.01) A61K 31/00 (2006.01) A61K 31/165 (2006.01) A61K 31/353 (2006.01) A61K 31/382 (2006.01) A61K 31/397 (2006.01) A61K 31/40 (2006.01) A61K 31/454 (2006.01) A61K 31/496 (2006.01) A61K 31/5377 (2006.01) A61K 31/541 (2006.01) A61K 31/55 (2006.01) A61P 3/00 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2473232
The invention relates to a method of treating a diabetic condition by administering a therapeutically effective amount of a histamine-3 receptor antagonist, including benzofuran and benzopyran derivatives of formula (I), aminoalkoxybiphenylcarboxamide compounds of formula (III), and aminoetherbiphenyl compounds of formula (IV) as described herein.
Méthode de traitement d'un état diabétique par administration d'une quantité thérapeutiquement efficace d'un antagoniste de récepteur d'histamine-3, dont des dérivés de benzofuranne et de benzopyranne de formule (I), des composés aminoalcoxybiphénylcarboxamide de formule (III), et des composés aminoétherbiphényle de formule (IV), tels qu'ils sont décrits dans le descriptif.
Bennani Youssef L.
Bush Eugene N.
Cowart Marlon D.
Hancock Arthur A.
Jacobson Peer B.
Abbott Laboratories
Torys Llp
LandOfFree
Histamine-3 receptor ligands for diabetic conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Histamine-3 receptor ligands for diabetic conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histamine-3 receptor ligands for diabetic conditions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1900031